‌

Actions

Action Type

‌
‌

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

Ask AI

Overview

Detailed Summary

Apollo Hospitals Enterprise Ltd is a pan‑India integrated healthcare provider operating hospitals, diagnostics, primary care clinics, an omni‑channel pharmacy distribution network and a large digital healthcare platform, with a consolidated network that includes 76 hospitals, ~10,325 capacity beds and material subsidiaries Apollo HealthCo and AHLL delivering out‑of‑hospital care and retail diagnostics.
Q3 FY26 consolidated revenues grew 17% year‑on‑year to ₹64,774 million with EBITDA up 27% to ₹9,653 million and PAT up 35% to ₹5,023 million, driven by 14% healthcare services growth, 20% HealthCo revenue growth and AHLL diagnostics expansion; digital losses narrowed significantly and HealthCo cash profit doubled versus prior year.
Apollo is pursuing an aggressive capacity build and M&A agenda: a ~₹8,200 crore bed expansion pipeline to add ~4,444 beds over FY26–FY30, plus a composite scheme to spin and list the combined HealthCo/Keimed entity as NewCo, an initiative that reconfigures ownership and aims to unlock value through listing by Q4 FY27.
Digital and platform businesses are scaling: Apollo 24|7 reports ~46 million registered users and ~9.5 lakh daily active users, platform GMV grew ~28% in Q3 FY26, Apollo Pharmacy operates 7,113 stores, and Apollo is integrating AI, telehealth and insurance solutions to increase omni‑channel customer journeys and diagnostic/pharmacy penetration across India.

Sector: Healthcare
Industry: Hospitals / Medical Services
Market Cap: 1,08,388 Cr
Volatility: Low Risk
P/E Ratio: 59.5
Industry P/E: 59.9
PEG Ratio: 3.0
P/B Ratio: 11.9
52W High: 8,099.00
52W Low: 6,002.15

Sales CAGR

1Y: 14.35%
3Y: 10.38%
5Y: -3.49%
10Y: 4.36%

Profit CAGR

1Y: 60.97%
3Y: 31.31%
5Y: 22.49%
10Y: 16.26%

ROE

TTM: 18.39%
3Y: 14.06%
5Y: 13.16%
10Y: 11.19%

ROCE

TTM: 16.07%
3Y: 14.90%
5Y: 14.25%
10Y: 12.32%

Technicals

‌

Forecasts

Unlock Premium Features

Analyst Target, Price, EPS and Revenue Projections

Upgrade

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
APOLLOHOSP	7514.15	1,08,388 Cr	59.48	11.93	0.17	18.39	16.07	8.50
MAXHEALTH	1053.65	1,02,530 Cr	70.29	10.20	0.14	13.50	12.81	8.72
FORTIS	916.90	69,222 Cr	68.73	7.34	0.11	10.75	12.26	6.53
NH	1826.60	37,212 Cr	43.90	9.17	0.25	20.82	17.75	10.07
ASTERDM	601.00	31,082 Cr	85.73	7.43	0.80	8.18	10.11	4.60
MEDANTA	1136.55	30,467 Cr	53.94	8.22	0.00	15.15	16.83	9.50
KIMS	683.60	27,354 Cr	93.39	12.05	0.00	14.80	10.88	4.75

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Sales	4,847	4,851	4,944	5,086	5,589	5,527	5,592	5,842	6,304	6,477
Expenses	4,219	4,237	4,303	4,411	4,774	4,765	4,823	4,990	5,362	5,512
Operating Profit	627	614	640	675	816	762	770	852	941	965
OPM %	12.95	12.65	12.96	13.27	14.59	13.78	13.76	14.58	14.93	14.90
Other Income	26	29	37	49	44	69	72	54	61	49
Interest	111	113	119	116	118	110	115	108	110	113
Depreciation	163	167	190	177	185	185	211	215	218	219
Profit Before Tax	379	363	368	430	557	536	516	583	675	682
Tax %	34.35	29.98	29.82	26.63	29.01	29.24	19.59	24.32	26.78	24.30
Net Profit	249	254	258	316	396	379	415	441	494	516
EPS in Rs	16.20	17.06	17.65	21.23	26.34	25.89	27.10	30.10	33.19	34.94

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	7,256	8,243	9,617	11,247	10,560	14,663	16,613	19,059	21,794	22,551
Expenses	6,527	7,450	8,554	9,660	9,423	12,478	14,563	16,669	18,772	19,352
Operating Profit	729	793	1,064	1,587	1,137	2,185	2,050	2,391	3,022	3,199
OPM %	10.04	9.62	11.06	14.11	10.77	14.90	12.34	12.54	13.87	14.18
Other Income	65	32	32	225	106	372	90	108	233	238
Interest	257	295	327	533	449	379	381	449	459	450
Depreciation	314	359	396	620	573	601	615	687	758	795
Profit Before Tax	222	171	373	660	221	1,578	1,144	1,363	2,039	2,192
Tax %	40.96	65.27	46.54	34.12	38.38	30.23	22.40	32.70	26.19	25.60
Net Profit	131	60	199	435	136	1,101	888	917	1,505	1,631
EPS in Rs	—	—	16.64	31.64	10.56	73.42	56.96	62.50	100.56	125.33
Dividend Payout %	37.78	59.24	35.38	18.35	27.93	16.00	26.33	25.60	12.59	—

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	70	70	70	70	70	72	72	72	72	72
Reserves	3,262	3,244	3,182	3,264	3,270	4,531	5,551	6,126	6,864	8,140
Borrowings	2,633	3,024	3,303	3,450	3,350	4,160	4,068	4,332	5,333	7,864
Other Liabilities	1,396	1,782	2,058	2,400	4,650	2,654	3,578	3,898	4,485	4,581
Total Liabilities	7,360	8,119	8,613	9,183	11,338	11,417	13,269	14,428	16,753	20,657
Fixed Assets	3,997	4,583	4,766	4,975	7,426	6,773	8,291	8,516	9,661	10,985
CWIP	562	347	712	822	236	234	46	610	873	921
Investments	352	414	359	468	440	1,348	821	578	990	2,490
Other Assets	2,448	2,775	2,776	2,918	3,237	3,062	4,112	4,725	5,230	6,261
Total Assets	7,360	8,119	8,613	9,183	11,338	11,417	13,269	14,428	16,753	20,657

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	597	623	537	905	1,293	1,265	1,696	1,377	1,920	2,136
Cash from Investing Activity	-888	-1,152	-405	-711	-289	-880	-747	-857	-1,537	-3,381
Cash from Financing Activity	330	477	-108	-215	-910	-340	-792	-633	-311	1,317
Net Cash Flow	39	-52	24	-20	95	44	158	-113	72	73

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoters	29.33%	29.33%	29.33%	29.33%	29.33%	29.33%	29.33%	29.33%	29.34%	29.34%	28.02%	28.02%
FIIs	46.96%	47.93%	46.15%	46.25%	45.63%	43.92%	45.37%	45.27%	42.74%	1.61%	44.20%	43.54%
DIIs	17.99%	17.24%	18.83%	19.10%	19.77%	21.37%	20.18%	20.20%	22.51%	21.57%	21.35%	21.74%
Public	5.71%	5.50%	5.69%	5.32%	5.26%	5.38%	5.12%	5.19%	5.41%	47.49%	6.43%	6.71%
Total Shareholders	1,31,937	1,20,030	1,31,565	1,19,578	1,30,664	1,27,754	1,19,245	1,27,802	1,34,058	1,41,007	1,60,556	1,78,648

Market Transactions

Unlock Premium Features

Analyst Target, Price, EPS and Revenue Projections

Upgrade

Projection

Unlock Premium Features

Get In-depth insights on EPS and Revenue forecasts

Upgrade

Documents

Presentations

Concalls

Reports

Presentations

Investor Presentation

Q3 FY26

Investor Presentation

Q2 FY26

Investor Presentation

Q1 FY26

Investor Presentation

Q4 FY25

Available on Pro Plan

Unlock reports, presentations, and AI-powered insights.

Investor Presentation

Q3 FY25

Available on Pro Plan

Unlock reports, presentations, and AI-powered insights.

Investor Presentation

Q2 FY25

Available on Pro Plan

Unlock reports, presentations, and AI-powered insights.

Investor Presentation

Q1 FY25

Available on Pro Plan

Unlock reports, presentations, and AI-powered insights.

Investor Presentation

Q4 FY24

Showing 1 - 8 of 25

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Investor Presentation

5 days ago

Apollo Hospitals Investor Presentation Q3 FY26

Apollo Hospitals has disclosed its investor presentation detailing the financial results for the three and nine months ended December 31, 2025, in compliance with SEBI regulations.

Acquisition Announcement

5 days ago

Acquisition of Belenus Champion Hospitals

Apollo Hospitals announces the acquisition of Belenus Champion Hospitals by its subsidiary for Rs 1,650 million, boosting its healthcare footprint.

Dividend Announcement

5 days ago

Interim Dividend Announcement

Apollo Hospitals has fixed the record date as 16th February 2026 for the payment of an interim dividend of Rs.10 per share.

Dividend Announcement

5 days ago

Apollo Hospitals Declares Interim Dividend

Apollo Hospitals Enterprises announced an interim dividend of Rs. 10 per share for the financial year ending March 31, 2026.

Dividend Announcement

5 days ago

Apollo Hospitals Announces Interim Dividend Payment

The Board of Apollo Hospitals has declared an interim dividend of Rs.10 per share, with a record date set for February 16, 2026, and payment by February 27, 2026.

Dividend Announcement

5 days ago

Dividend Announcement by Apollo Hospitals

Apollo Hospitals has declared an interim dividend of Rs. 10 per share, effective for the financial year ending March 31, 2026, with a record date set for February 16, 2026.

Showing 1 - 6 of 7

AI Mode

Ask AI

Frequently Asked Questions about Apollo Hospitals Enterprise Ltd

Apollo Hospitals Enterprise Ltd (APOLLOHOSP) is currently trading at 7,514.15 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Apollo Hospitals Enterprise Ltd is a pan‑India integrated healthcare provider operating hospitals, diagnostics, primary care clinics, an omni‑channel pharmacy distribution network and a large digital healthcare platform, with a consolidated network that includes 76 hospitals, ~10,325 capacity beds and material subsidiaries Apollo HealthCo and AHLL delivering out‑of‑hospital care and retail diagnostics. Q3 FY26 consolidated revenues grew 17% year‑on‑year to ₹64,774 million with EBITDA up 27% to ₹9,653 million and PAT up 35% to ₹5,023 million, driven by 14% healthcare services growth, 20% HealthCo revenue growth and AHLL diagnostics expansion; digital losses narrowed significantly and HealthCo cash profit doubled versus prior year. Apollo is pursuing an aggressive capacity build and M&A agenda: a ~₹8,200 crore bed expansion pipeline to add ~4,444 beds over FY26–FY30, plus a composite scheme to spin and list the combined HealthCo/Keimed entity as NewCo, an initiative that reconfigures ownership and aims to unlock value through listing by Q4 FY27. Digital and platform businesses are scaling: Apollo 24|7 reports ~46 million registered users and ~9.5 lakh daily active users, platform GMV grew ~28% in Q3 FY26, Apollo Pharmacy operates 7,113 stores, and Apollo is integrating AI, telehealth and insurance solutions to increase omni‑channel customer journeys and diagnostic/pharmacy penetration across India.

Over the past 52 weeks, Apollo Hospitals Enterprise Ltd has traded between a low of ₹6,002.15 and a high of ₹8,099.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Apollo Hospitals Enterprise Ltd has a market capitalization of approximately 1,08,388.47. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Apollo Hospitals Enterprise Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 59.48 and operates in the Healthcare sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 1,08,388.47 Cr, Apollo Hospitals Enterprise Ltd is classified as a Large Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Apollo Hospitals Enterprise Ltd operates in the Healthcare sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Apollo Hospitals Enterprise Ltd is 59.48. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

The CGHS rate revision is the Indian government's first major update in 15 years to the prices paid for nearly 2,000 medical procedures for central government employees and pensioners. It's important because it aligns reimbursement rates closer to market levels, improving profitability for hospitals.

For Q3 FY26, Apollo Hospitals reported a 35% year-on-year increase in consolidated net profit to ₹502 crore. Consolidated revenue grew by 17% to ₹6,477 crore, and EBITDA rose by 27% to ₹965 crore.

Analyst price targets for Apollo Hospitals vary. Citi has set a high target of ₹9,600, while ICICI Securities has a more conservative target of ₹8,080. The average 1-year price target from Wall Street analysts is approximately ₹8,911.

Apollo Hospitals reported a 35% year-on-year increase in consolidated net profit to Rs 502 crore. Consolidated revenue grew by 17% to Rs 6,477 crore, and EBITDA increased by 27% to Rs 965 crore.

Apollo Hospitals Enterprise Ltd

Actions

AI Mode

Ask AI

Utility

Company

Overview

Financial Ratios

Technicals

Forecasts

Unlock Premium Features

Upgrade

Peers

Price Chart Comparison

Financial Statements

AI Powered Summary

Ask AI

Consolidated Quarterly Results (in ₹ Crores)

Consolidated Profit Loss (in ₹ Crores)

Consolidated Balance Sheet (in ₹ Crores)

Consolidated Cash Flows (in ₹ Crores)

Shareholdings

Shareholding History

Market Transactions

Unlock Premium Features

Upgrade

Projection

Unlock Premium Features

Upgrade

Documents

Actions

Announcements

Apollo Hospitals Investor Presentation Q3 FY26

Acquisition of Belenus Champion Hospitals

Interim Dividend Announcement

Apollo Hospitals Declares Interim Dividend

Apollo Hospitals Announces Interim Dividend Payment

Dividend Announcement by Apollo Hospitals

AI Mode

Ask AI

Frequently Asked Questions about Apollo Hospitals Enterprise Ltd

What is Apollo Hospitals Enterprise Ltd share price today?

What does Apollo Hospitals Enterprise Ltd do?

What is the 52-week high and low of Apollo Hospitals Enterprise Ltd?

What is the market capitalization of Apollo Hospitals Enterprise Ltd?

Should I consider investing in Apollo Hospitals Enterprise Ltd stock?

Is Apollo Hospitals Enterprise Ltd a large-cap, mid-cap, or small-cap stock?

Which sector does Apollo Hospitals Enterprise Ltd belong to and why does it matter?

What is the PE ratio of Apollo Hospitals Enterprise Ltd?

What is the CGHS rate revision and why is it important?

What were Apollo Hospitals' key financial results for Q3 FY26?

What is the latest price target for Apollo Hospitals stock?

What were the key financial highlights of Apollo Hospitals' Q3 FY26 results?

Technicals

Documents

Oscillators

Bearish

Overall

Bullish

Moving Averages

Bullish

Overall

Bullish

Stock Summary and Key Metrics

Investment Checklist

Investment Checklist

Forecasts

Unlock Premium Features

Upgrade

Projection

Unlock Premium Features

Upgrade

Overview

Financial Ratios

Shareholdings

Shareholding History

Market Transactions

Unlock Premium Features

Upgrade

Financial Statements